{"id":"W4376102342","doi":"10.5281/zenodo.7919555","title":"Imatinib mesylate: Recent drug used in oncology","year":2023,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Imatinib mesylate; Drug; Imatinib; Medicine; Mesylate; Anticancer drug; Oncology; Medical physics; Internal medicine; Pharmacology; Chemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006620226,0.0004009601,0.0007370653,0.002686056,0.0004315328,0.001086126,0.0004135843,0.000739463,0.02073125],"category_scores_gemma":[0.00234238,0.0001129146,0.0004603998,0.005576098,0.0005122613,0.001715088,0.0006692414,0.001170958,0.007885983],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007224975,"about_ca_system_score_gemma":0.00119988,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009271933,"about_ca_topic_score_gemma":0.002402544,"domain_scores_codex":[0.9993984,0.0001180981,0.0001490427,0.00008571325,0.0002008617,0.00004795832],"domain_scores_gemma":[0.9988637,0.0002657569,0.0003609971,0.00005098864,0.0003338521,0.0001247186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003449906,0.00004214795,0.002673712,0.01057962,0.0001098391,0.001585237,0.0001553618,0.0001456671,0.002158908,0.005632835,0.2741642,0.7024074],"study_design_scores_gemma":[0.00002332412,0.00005565269,0.003358973,0.001306906,0.00008039983,0.003009575,0.00004657359,0.00004456688,0.000422866,0.0005544611,0.9910858,0.00001080016],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.005221279,0.9001358,0.0007466049,0.01624547,0.008500049,0.0001054494,0.00259095,0.0001014278,0.06635289],"genre_scores_gemma":[0.05310439,0.8694308,0.002977508,0.01735495,0.009036826,0.0001381289,0.004311442,0.00008261529,0.04356327],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02073125,"threshold_uncertainty_score":0.06935292,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0583389281460337,"score_gpt":0.3151679195635627,"score_spread":0.256828991417529,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}